Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnosing Clinically Significant Prostate Cancer in African American and White Men Phase II, Randomized Clinical Trial, Multi-center, MR-Guided vs. 12-core Systematic Random Biopsy, Localized Prostate Cancer

NCT03234556 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT03234556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03234556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnosing Clinically Significant Prostate Cancer in African American and White Men Phase II, Randomized Clinical Trial, Multi-center, MR-Guided vs. 12-core Systematic Random Biopsy, Localized Prostate Cancer
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 25, 2017
Completion date
May 23, 2028
Enrollment
288 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

elevated psa, health status unknown